The makers of Plavix®, Sanofi-Aventis and Bristol-Myers Squibb have tentatively settled a patent dispute on the drug.
Plavix®, an anti-clotting agent is the world’s second-best selling drug have been settled to be generically manufactured by Apotex, a Canadian generic drug maker, beginning September 2011, eight months before the United States patent is expected to expire. The companies said they would split the payments to Apotex 50-50, adding that they expected to establish reserves this quarter for the minimum estimated amount of the payment.
Under the agreement, Apotex will make undisclosed royalty payments to the companies beginning in 2011.
Read the news report on NY Times.
Interesting news -- thanks for the updates at this site, Gloria! Ellen
Posted by: Ellen Weber | April 15, 2006 8:03 PM | Permalink to Comment